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                                                 Abstract 
Ehrlichia chaffeensis a tick transmitted Anaplasmataceae family pathogen 
responsible for human monocytic ehrlichiosis. Differential gene expression appears to 
be an important pathogen adaptation mechanism for its survival in dual hosts. One of 
the ways to test this hypothesis is by performing mutational analysis that aids in altering 
the expression of genes. Mutagenesis is also a useful tool to study the effects of a gene 
function in an organism. Focus of my research has been to prepare several modified 
Himar transposon mutagenesis constructs for their value in introducing mutations in E. 
chaffeensis genome. While the work is in progress, research team from our group used 
existing Himar transposon mutagenesis plasmids and was able to create mutations in E. 
chaffeensis. Multiple mutations were identified by Southern blot analysis. I redirected 
my research efforts towards mapping the genomic insertion sites by performing the 
semi-random two step PCR (ST-PCR) method, followed by DNA sequence analysis. In 
this method, the first PCR is performed with genomic DNA as the template with a primer 
specific to the insertion segment and the second primer containing an anchored 
degenerate sequence segment. The product from the first PCR is used in the second 
PCR with nested transposon insertion primer and a primer designed to bind to the 
known sequence portion of degenerate primer segment. This method aided in 
identifying the genomic locations of four E. chaffeensis mutants and also was valuable 
in confirming four other sites mapped previously by the rescue cloning method. This is 
the first mutational analysis study in the genome of an Ehrlichia species. Mapping the 
genomic transposon insertion sites is the first critical step needed for the continued 
  
research to define the importance of the mutations in understanding the pathogenesis 
caused by the organism.  
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Ehrlichia chaffeensis is an obligate intracellular Gram negative bacterium, and it is the 
causative agent of the disease human monocytic ehrlichiosis (HME). The organism 
belongs to the order Rickettsiales and the family Anaplasmataceae. The pathogen is 
transmitted by an infected tick Amblyomma americanum, commonly referred as the lone 
star tick [1]. HME is one of the most important tick-borne rickettsiale diseases in the 
USA. HME cases are reported from the south-central, southeastern, and Mid-Atlantic 
States of the USA, which corresponds to the geographical distribution of the lone star, 
tick. The symptoms of this disease may vary and may include persistent high fever, 
headache, malaise, and muscle aches [2, 3]. Ehrlichiosis can be fatal if not treated with 
an antibiotic, particularly in immune compromised and elderly patients [4]. The 
estimated case fatality rate (i.e. the proportion of persons who die as a result of their 
infection) is about 1.8%. Patients who are treated early may recover quickly on 
outpatient medication, while those who experience a more severe course of the disease 
may require intravenous antibiotics, prolonged hospitalization or intensive care. 
Diagnosis of HME is mainly based on clinical signs of the disease and followed by 
confirmatory laboratory test results. Some indicatives of HME in confirmatory laboratory 
tests include low white blood cell count, low platelet count and elevated liver enzymes, 
while the clinical signs resemble flue like illness with persistent high fever. HME is an 
emerging disease with number of cases increasing every year. The wide spread 
distribution of the reservoir host (white tailed deer) and the tick vector can also be a 
reason for the increased incidence of HME reported in recent years [5, 6]. 
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Discovery  
 
E. chaffeensis is an obligatory intracellular tick-transmitted rickettsiale bacterium 
in the family Anaplasmataceae of class Alpha Proteobacteria. It was first discovered in 
April 1986, in Arkansas in the peripheral blood smear of patients at Fort Chaffee, 
Arkansas  [7]. The organism was isolated in cell culture and characterized by molecular 
techniques and was named as E. chaffeensis [8, 9]. It is closely related to the members 
of the genera Anaplamsa, Wolbachia and Neorickettsia belonging to the family 
Anaplasmataceae.  
Statistics and Epidemiology 
 
HME is identified as a reportable disease from 1999 and Centers for Disease 
Control and prevention (CDC) compiles the number of cases reported by state health 
departments. Compared to E. chaffeensis, number of cases with another species of 
Ehrlichia causing a disease in people, E. ewingii, are considerably less [10, 11]. The 
number of HME cases reported to CDC has increased steadily from 200 cases in the 
year 2000, to 961 cases in 2008 [10]. The incidence (the number of cases for every 
million persons) of ehrlichiosis increased similarly, from less than 1 case per million 
persons in 2000 to 3.4 cases per million persons in 2008 [12, 13]. During the same time 
period, the annual case fatality rate which means the proportion of ehrlichiosis patients 
that died as a result of their infections has declined [14].  
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Geographical distribution 
 
HME is the most frequently reported disease from the southeastern and south-
central United States. The areas from which cases are reported correspond with the 
geographic distribution of the lone star tick (Amblyomma americanum), which is 
associated with transmission of both E. chaffeensis and E. ewingii. Most cases reported 
to the CDC are from the states of Missouri, Oklahoma, Tennessee, Arkansas, and 
Maryland [15]. Mainly three states Oklahoma, Missouri, and Arkansas account for about 
35% of all reported E. chaffeensis infections. Incidence of HME is also reported in 
China, Korea, Mali and Peru [13]. 
                Morphology 
 
Ehrlichia species are small, Gram-negative bacteria, round or ellipsoidal in 
shape. E. chaffeensis invade mononuclear phagocytes, such as monocytes and 
macrophages. The pathogen occupies cytoplasmic vacuoles, usually to form bacterial 
micro colonies known as morulae. Ehrlichia species cycle in nature between ticks and 
mammals, and can cause disease in many mammalian species. Ehrlichia species exist 
in two morphological forms during its life cycle, dense core cells which are the infective 
form and reticulate cells which are the non-infectious replicative form [16].  
             Pathogenicity 
 
E. chaffeesnsis being an obligatory pathogen infects and resides in the 
monocytes and macrophages in the blood and other organs including spleen, liver, 
lungs and bone marrow of the host. It may also infect lymphocytes but it has a strong 
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tropism towards monocytes and macrophages. Usually the clinical signs develop in 1-4 
weeks after the tick-bite [17]. Commonly the symptoms range from asymptomatic to 
mild flu-like symptoms, and sometimes might deteriorate into a fatal life threatening 
situation. Mostly common symptoms include malaise, fever, headache, muscle aches, 
chills, nausea and lymphadenopathy [10, 18]. Sometimes, there may also be cough, 
pharyngitis, swollen lymph nodes, vomiting, and possible changes in mental status[19]. 
Severe cases may include complicated situations such as septic shock-like syndrome, 
meningitis, organ damage [19]. Leucopenia, thrombocytopenia, and an increase in 
hepatic transaminase levels may be seen in the laboratory diagnosis [20]. Although 
people of all ages are susceptible to the disease, immune compromised people and 
elderly have greater chance of developing a severe disease [21].   
Diagnosis and treatment  
 
Since other bacterial and viral infections also have similar clinical signs, definitive 
diagnosis of HME requires the detection of pathogen by molecular methods. Thus, 
accurate description of tick-bite history and systematic laboratory diagnosis is very 
helpful in preliminary confirmation of this disease [18]. Routine laboratory diagnostic 
methods for preliminary examination include detecting peripheral blood smear, 
performing IFA and PCR. Confirmatory examination may also be possible by cell culture 
recovery of the pathogen [22-24]. For prevention and clearance of the infection, 
treatment with a tetracycline derivative is proven to be very effective [18, 25]. 
Specifically, doxycycline has better efficacy and is currently the drug of choice for 
treating HME patients. The drug binds to the 30S ribosomal subunit and prevents the 
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formation of peptide chains and therefore inhibits the bacterial protein synthesis and 
growth. There is no evidence for alternative treatments, as beta lactams, 
aminoglycosides and cephalosporins are not effective against E. chaffeensis.  
             Isolates 
 
Culture system for growing E. chaffeensis aided in the recovery of various 
isolates of the organism recovered from human patients and from deer. The organism is  
cultured in various cell lines including canine histiocytoma cell line (DH82 cells), cells 
Human monocytic leukemia cells (THP 1), human cervical epithelioid carcinoma cells 
(HeLa cells), Vero cells, and murine fibroblasts [26]. Most of the isolates of E. 
chaffeensis are generated from HME patients [27]. A few isolates are also established 
from the bacteria recovered from the reservoir host, white tailed deer. The Arkansas 
isolate isolated is the oldest and the most widely used one in research [27].   
Molecular Biology 
 
The complete genome sequence of E. chaffeensis strain Arkansas is reported 
recently and is available at the NCBI database [28]. The E. chaffeensis genome is 1.18 
Mb in size and consists of 1,115 open reading frames. It has a reductive genome and 
lacks genes for the biosynthesis of lipopolysaccharides and peptidoglycans. This is also 
observed in other related bacteria of the genera Anaplasma and Wolbachia belonging to  
the family Anaplasmataceae [29]. The GC % of E. chaffeensis is 20.1 and the average 
gene length is 840 base pairs. There are 604 genes coding for proteins with assigned 
functions and 314 are classified as genes coding for hypothetical proteins [30].   
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E. chaffeensis is unable to utilize glucose as a carbon or energy source and it is 
also auxotrophic for 14-17 amino acids [22, 30]. It must depend on the host for these 
amino acids and other metabolites. E. chaffeensis abundantly expresses more proteins 
involved in protein synthesis, and electron transport chain proteins [30].  E. chaffeensis 
has 40 genes encoding for transport and binding proteins. E. chaffeensis has the 
required genes for the biosynthesis of all necessary nucleotides, vitamins and cofactors 
like biotin, folate, FAD, NAD, CoA, thiamine and protohaem. The lack of required genes 
for the biosynthesis of lipopolysaccharide and common pili in Ehrlichia makes the 
envelope proteins important in providing a critical interface between the organism and 
its hosts. Whole genome sequence analysis revealed  the identification of 49 genes that 
encode for envelope proteins in E. chaffeensis which corresponds to 6.6 % of the total 
encoded proteins [28].   
Proteomics studies of E. chaffeensis identified one-fourth of the total open 
reading frames of the organism are expressed when it grows in macrophage and tick 
cell- cultures [31-33]. Mass spectrometric analysis identified 1,021 of E. chaffeensis 
proteins representing 92.3 % of the predicted bacterial proteomes [16] . Quantitative 
MS/MS analyses indicated that highly expressed proteins in E. chaffeensis included 
chaperones, enzymes involved in biosynthesis and metabolism, and outer membrane 
proteins such as P28/OMP-1 [16]. Proteomic analysis of infected host cells also showed 
that E. chaffeensis infection up regulated the expression of human proteins involved 
mostly in cytoskeleton components, vesicular trafficking, cell signaling, and energy 
metabolism, but down-regulated some pattern recognition receptors involved in innate 
immunity [34-36]. 
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              Outer membrane proteins  
 
E. chaffeensis genome contains 22 paralougs of tandemly arranged p28/omp-
1 genes encoding immunodominant major outer membrane proteins [37-39]. These are 
clustered in a 29 kb locus which is present downstream of the transcriptional regulator 
gene tr1. This gene organization is conserved among other Ehrlichia species like [40-
42]. The OMP1-P28 gene locus is among the most strain variable genomic regions [43]. 
Singu et al showed that these outer membrane proteins are differentially expressed in 
tick and macrophage cell lines [32]. 
Studies showed that immunization with a recombinant p28 protein protects mice 
from E. chaffeensis challenge. Polyclonal antibodies or monoclonal antibodies specific 
to p28 mediate protection of SCID mice from fatal infection with E. chaffeensis.  
            E. chaffeensis secretory system  
 
Secretory systems in bacteria help in delivering or translocating effector 
molecules across the bacterial cells to their exterior. Secretory systems play a major 
role in the virulence and pathogenesis of a pathogenic bacterium. Intracellular 
pathogenic bacteria are known to translocate a wide variety of effector substrates into 
their host cells to help in manipulating the host cell environment for the bacterial 
survival. There are many types of secretory systems found in Gram negative bacteria, 
namely; type I secretion system, type II secretion system, type III secretion system 
(T3SS or TTSS), type IV secretion system (T4SS or TFSS), type V secretion system 
(T5SS) and type VI secretion system (T6SS). 
9 
 
Based on the genomic domain searches, Hotopp et al suggested that the 
bacterial type II, III, V and VI secretion components are not present in E. chaffeensis 
[30]. T4SS and type I secretory system is identified in E. chaffeensis and the secreted 
products function as effectors in the host cells to facilitate the infection and intracellular 
replication of Ehrlichia [44, 45]. 
Cell Biology  
 
E. chaffeensis infects the macrophages/monocytes, the cells with antimicrobial 
defenses. It is known that several pathogenic microorganisms have developed unique 
strategies in support of avoiding the activation of pattern recognition receptors.  E. 
chaffeensis lost all the genes coding for the biosynthesis of lipopolysaccharide (LPS) 
and most of the genes for peptidoglycan biosynthesis [29]. Because of this, effective 
innate immune response targeted to the LPS of the organism is not possible. E. 
chaffeensis survives and replicates inside the midgut and salivary glands of its tick 
vectors. Arthropods also possess a strong innate immune system similar to vertebrates 
in support of overcoming the pathogen infections. It works by recognizing the pathogen-
associated molecular pattern molecules (PAMPS) on bacteria. Some pathogenic 
bacteria also are known to escape the arthropod immune system as they do not 
express PAMPS [46]. The loss of genes coding the biosynthesis of LPS and 
peptidoglycan turns out to be an important adaptation strategy for E. chaffeensis and 
aids in evading vector immune system. [47, 48].  
Lin et al have shown that E. chaffeensis requires cholesterol and have the ability 
of up taking the cholesterol from host [49]. With the aid of biochemical analysis and 
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fluorescence microscopy the authors demonstrated that E. chaffeensis contains high 
levels of membrane cholesterol [29]. Moreover, the absence of cholesterol causes ultra-
structural changes to the organism’s membrane structure.  E. chaffeensis organisms 
when treated with cholesterol extraction agents, become incapable of infecting host 
cells and lose their viability [29]. Removal of cholesterol from the host cell in a culture 
system also impacts the bacterial ability to infect host cells. The dependency of E. 
chaffeensis on cholesterol for infection and replication in vitro suggests that increased 
blood cholesterol levels may increase the severity of disease in mammalian hosts. 
              Life cycle  
 
E. chaffeensis requires both vertebrate and tick hosts to complete its lifecycle 
[16].  White tailed deer is the primary reservoir host. The pathogen is also detected in 
domestic dogs which may serve as a secondary host [50]. The lone star tick, 
Amblyomma americanum is the tick vector harboring the pathogen. Humans are 
considered incidental hosts acquiring infections from the bite of an infected tick bite [51-
53]. After transmission to a mammalian host, E. chaffeensis replicates inside the 
monocytes/macrophages by subverting the immune responses of the host. The 
bacterium enters the host cells through endocytosis and resides in an intracellular 
compartment, in a phagosome [54, 55]. The inclusion does not acquire the components 
of late endosomes or lysosomes [56]. E. chaffeensis inclusions have the characteristics 
of early endosomes. They possess the early endosome markers like Rab 5, early 
endosome antigen 1 (EEA) and the vacuolar (H+) ATPase. These inclusions fuse with 
endosomes containing transferrin and transferrin receptors [57]. 
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E. chaffeensis forms dense intracellular micro colonies, termed as morulae, since 
they look like mulberries when blood smear of infected culture samples are stained and 
observed under a light microscope. Electron micrographs show that E. chaffeensis has 
enveloped inner and outer membranes [58]. The organisms are pleomorphic in shape 
and their size may vary from 0.2 to 2.0 µm in diameter. Inside the host cells E. 
chaffeensis appears in two forms, dense-cored cell and reticulate cells [58]. The two 
morphological structures are observed in both mammalian and tick cells [59-62].  
 Initially small dense cored cells enter the host cells during infection which are 
internalized and developed into large reticulate cells. The reticulate cells transform into 
dense cored cells prior to release [63, 64]. After a lag phase of growth which occurs for 
about 24 h, an exponential growth phase occurs which lasts for up to  72 h ,followed by 
a stationary phase from 72 h to 96 h [65, 66].  
             Host response to E. chaffeensis infection  
Infection studies with E. chaffeensis were done in mice for studying the role of 
cellular and humoral immunity. Wild-type mice clear the infection within about 14 days 
[67]. On the contrary, the infection persists from several weeks to several months in 
mice with defective macrophage and T-cell functions [67] . Tlr 4 mutant mice produce 
decreased levels of nitric oxide and interleukin-6 showing the importance of 
macrophages in clearing infection. Mice without functional MHC-II genes fail to clear the 
infection which suggests that functional MHC system is essential for protection against 
E. chaffeensis [68, 69]. CD4+T-cell deficient mice are highly susceptible for E. 
chaffeensis infection whereas CD8+T-cell deficient mice are resistant to low doses of 
inoculum but susceptible to high doses [69]. 
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             Host cell gene expression during E. chaffeensis infection  
 
E. chaffeensis infection alters the host gene expression. Zhang et al showed that 
the transcriptional levels of approximately 5% of host cell genes are significantly altered 
within 24 h following E. chaffeensis infection [62]. The genes with altered gene 
expression include those responsible for many important cellular processes, such as 
genes coding for apoptosis inhibition, cell cycle regulation and differentiation, signal 
transduction, proinflammatory cytokines, biosynthetic and metabolic proteins, and 
membrane trafficking proteins [62, 70] . 
 
The microarray analysis of host cells during E. chaffeensis infection revealed that 
the bacterium manipulates genes related to three primary areas of the host responses. 
Upon infection the transcription of cytokines is repressed. Host cell cytokines like IL-12, 
IL-15, and IL-18 which are important for innate and adaptive immunity against 
intracellular bacteria are repressed. The host cytokines stimulates NK cells and T helper 
1 cells to produce gamma interferon (IFN-γ), which is responsible for activating the 
macrophages to kill the phagocytized bacteria. IL-12 and IL-15 are known to activate 
NK cells and cytotoxic T lymphocytes, to kill the infected host cells. Repression of the 
host cytokines expression may be a survival adaptation mechanism of E. chaffeensis 
[62, 71]. 
             Inhibition of apoptosis in infected host cells  
 
Apoptosis is an innate immune mechanism of the host cells which restricts the 
replication of internalized pathogens. E. chaffeensis also upregulates NF-kB and other 
13 
 
apoptosis inhibitors. These help in enhancing the host cell survival. During infection host 
cells apoptosis inhibitors such as IER3 (immediately early response), BirC3 (baculoviral 
IAP repeat- containing protein), and BCL2 are induced. Apoptosis inducers such as BIK 
(BCL2 interacting killer), and BNIP3L (BCL2/adenovirus E1B 19-Kda interacting protein 
3 like) are inhibited following infection with E. chaffeensis. Thus inhibitions of the host 
apoptotic mechanism provide the bacterium the chance for prolonged replication and 
survival [72, 73]. 
Manipulation of host membrane trafficking machinery   
 
It is showed that E. chaffeensis inhibits the host cell genes involved in membrane 
trafficking. It inhibits the maturation of the early endosomes so that it can escape from 
the lysosome mediated destruction. During the first hour of infection E. chaffeensis 
represses the production of markers STX16 (syntaxin 16) and Rab5 [16]. The bacterium 
induces the production of vimentin a SNAP 33 reservoir and a component of membrane 
fusion machinery. E. chaffeensis may modulate phagosome-lysosome fusion by 
regulating the expression of Rab5 and SNAPs of the infected macrophage. Together, 
the detailed studies described in the literature demonstrate that E. chaffeensis is 
evolved to adapt to vertebrate and tick hosts and also alters host gene expression in 
support of its intracellular survival [16].  
Mutagenesis in E. chaffeensis 
 
One of the striking features of E. chaffeensis is its dual host life cycle and its 
prolonged persistence in both tick and vertebrate hosts. The mechanism of persistent is 
14 
 
not well studied. There may be several ways by which the pathogen could persist. One 
important hypothesis is that differential gene expression may be an important adaptive 
mechanism used by E. chaffeensis to support its continued survival in dual host 
environment [74]. Recent studies from our laboratory demonstrated that the pathogen’s 
differential gene expression during growth in tick cells and mammals is a major 
contributor to its dual host adaptation [33, 75-77]. The importance of differential gene 
expression may be better understood by performing mutational analysis on the critical 
genes of E. chaffeensis. Creating mutations in E. chaffeensis remains a challenge 
because it is primarily an obligate intra-phagosomal pathogen with a limited survival in 
the extracellular environment [43]. 
 Mutagenesis in bacteria is possible by creating insertion mutations at random or 
at specific genomic locations.  Random mutagenesis approaches have been described 
in creating effective gene mutations in both Gram positive and Gram negative bacteria, 
including in Rickettsial organisms. For example, transposon based mutagenesis is 
described in Rickettsia and Anaplasma species [78].  Similarly, targeted mutagenesis is 
reported for Rickettsia species. Two methods of targeted mutagenesis include 
homologous recombination and Targetron based method [79]. Homologous 
recombination method is utilized for creating mutations in Rickettsia species [80]. 
Targetron mutation method is an efficient method in creating mutations in both Gram 
positive and Gram negative bacteria, but it is not described in rickettsiales. Targetron 
method involves the use of a modified mobile group 2 intron [81, 82]. Recently, studies 
have shown that Himar 1 transposase system is useful in creating insertion mutations at 
random in various bacterial genomes [81]. This method is also used in creating 
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mutations in intraphagosomal bacteria such as A. phagocytophilum, A. marginale and 
Coxiella burnetti Similarly other transposon systems, like TN5 and EZTN, have been 
used to create mutations in C. burnetti [83, 84]. 
Mapping of transposon insertion sites 
 
One of the important challenges in random mutagenesis is the identification of 
genomic sites where mutations are introduced.  Several molecular methods are 
described in the literature for mapping mutation sites.  Total genomic DNA from 
transposed organisms can be assessed by Southern blot analysis targeting to a DNA 
inserted by the Transposon system. This method greatly aids in identifying inserts within 
a genome. Mutants can also be selected if inserts include an antibiotic resistance 
cassette. Specific insertion site identification within a genome requires additional 
molecular methods such as PCR and sequencing.  
Methods described in the literature for mapping the random insertion mutations 
include rescue cloning, inverse PCR, nested PCR and semi random nested PCR [83].   
One of the commonly used methods of identifying transposon insertion sites is a rescue 
cloning method. Rescue cloning is a commonly used method in which a genomic DNA 
containing the insertion sites was digested using a restriction enzyme that does not 
have restriction sites within the transposon insertion segments. Then the digested 
fragments are ligated into plasmid vector, transformed into an E. coli strain and the 
insertion-specific fragments are identified by screening for plasmids containing antibiotic 
resistance cassette originating from the insertion site [83]. Genomic sequences at the 
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insertion sites can then be identified by performing DNA sequence analysis of the 
recombinant plasmids by following standard molecular methods. 
The semi random, two step PCR (ST-PCR) 
 
Chun et al reported a variant of conventional PCR which aids in the rapid 
amplification of uncharacterized transposon tagged DNA sequences [85]. It is referred 
as the semi random, two step PCR (ST-PCR). This method involves two successive 
PCR reactions and two pairs of PCR primers. In the first reaction, one primer contains 
sequence complimentary to the transposon sequence and the second primer contains a 
20-nucleotide sequence followed by a ten bases of degenerate sequence and a specific 
five nucleotide sequence GATAT.  A subset of these primers anneal to an unknown 
DNA sequence near the transposable element. These primers will allow the initial 
amplification. The second primer pair is designed to be specific for the amplicons 
produced in the first round; one primer is targeted internal to the amplicons containing 
the transposon insertion sequence and the other primer is specific in binding to the 20-
nucleotide sequence present in the semi random primer used in the first PCR.  
Insertion-specific sequences can be generated during the second PCR reaction when 
using the products of the first PCR as templates. The final products from the second 
round are gel isolated and subjected to DNA sequence analysis to identify the genomic 
insertion sites. ST-PCR is simple, efficient and rapid in identifying transposon insertions.   
Some software’s applications are also available which can aid in predicting the location 
of transposon insertion sites.  Several next-generation sequencing methods are also 
described in mapping transposon mutation sites [86].   
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SCOPE OF THE RESEARCH 
 
Research has shown that E. chaffeensis employs differential gene expression for 
its survival in its two different hosts. Indeed, recent studies revealed that several 
proteins are differentially expressed in tick and mammalian host environments. Little is 
known about the molecular mechanism by which the bacterium changes its gene 
expression.   
One of the best ways to study the impact of differential gene expression is to stop 
the gene expression of a subset of genes likely important and observe their effects on 
the bacterial growth in vertebrate and tick host environments in vitro and in vivo.  This 
may be accomplished by creating mutations in bacterial genes.  No successful 
mutagenesis methods are described in literature for E. chaffeensis. Our research group 
has been working for some time in evaluating different mutagenesis methods to create 
mutations in E. chaffeensis. Mutagenesis of a specific bacterial gene can be done in two 
ways; homologous recombination or by utilizing a modified group II intron-mediated 
mutational method. Although there is some success in cresting mutations, the targeted 
approach may not be ideal for E. chaffeensis because it is difficult to predict which 
genes are critical for the bacterial survival as most genes of the organism are expressed 
during its replication cycle in vertebrate and tick host cell environments. Indeed, 
research described by our group demonstrate that the targeted mutagenesis methods 
do aid in generating gene inactivation mutations, but the mutant organisms survive only 
for a very short span of time under in vitro culture conditions. Random mutagenesis by 
utilizing a transposon insertion mutation method may aid in identifying genomic targets 
essential for the in vivo growth while not impacting the organism’s replication in vitro. 
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Mutagenesis experiments using Himar transposon system have been proven 
useful in several rickettsial pathogens. Our research team, in collaboration with Dr. 
Ulrike Munderloh’s group, has also been successful in creating random mutations at 
various genomic locations in E. chaffeensis. The identification of the genomic sites 
where the random mutations are present is an important goal in furthering our 
knowledge about assessing the impact of mutations on the pathogen’s growth. The 
primary focus on MS my research, therefore, is to fill-in this important gap of knowledge.  
In particular, the main focus of my research has been to map the mutation sites in E. 
chaffeensis genome. 
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                   Materials and Methods 
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Polymerase chain reaction (PCR) 
               
All PCRs were set up in a final reaction volume of 25 μl. The reaction mixture consisted 
of a final concentration of 1X PCR reaction buffer containing 50 nm of MgCl2, 10 nm of 
dNTP's, 10 pico moles each of forward and reverse primers, about 1 ng of template 
DNA, and 1 unit of Taq DNA polymerase (Invitrogen technologies, Carlsbad, CA).  The 
PCR temperature cycles followed an initial heating at 95°C for 2 min, followed by 40 
cycles of 95°C denaturation for 30 sec, primer annealing for 30 seconds carried out at 
appropriate temperatures calculated for each primer set, 72°C extension for 30 sec. The 
extension temperature for platinum High fidelity DNA polymerase was 68°C. The 
extension temperatures were increased to 1 min per each kb of expected amplicons 
length. Each reaction set included a negative control, which lacked a template but 
contained all the other reaction components. After a reaction is complete, the products 
were resolved on 0.9% agarose gels containing 10 ug/ml ethidium bromide, visualized 
under UV light and the images were captured using Kodak gel imaging system (Kodak, 
imaging systems). 
Restriction enzyme digestions 
 
All restriction enzyme digestions were performed in a total volume of 20 μl. The reaction 
mix included respective 1x restriction enzyme-specific reaction buffer, 1 μg of DNA, 1-2 
units of enzyme, 0.5 μl of BSA (10 μg/μl), and water to a final volume of 20 μl. Typically 
the restriction enzyme digestions were carried out at 37°C for 2 hours unless an 
enzyme requires a specific temperature. For the reactions that utilized two restriction 
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enzymes, a buffer optimal for both the enzymes according to the manufacturer’s 
instructions was utilized. 
             Phenol purification of DNA 
  
DNA fragments from all PCR reactions or restriction enzyme digestions were purified by 
phenol purification method. Typically, 3M sodium acetate was added to the final 
concentration of 0.3 M to a micro centrifuge tube containing DNA solution and final 
volume was adjusted to 200 μl with TE buffer. Two hundred micro liters of phenol (pH, 
8.0) was added, vortexed and centrifuged at 12,000 g for 15 min at 4°C. The top 
aqueous layer was transferred into a clean micro centrifuge tube and to which 200 μl of 
phenol:chloroform:isoamylalcohol (25:24:1 ratio) mixture was added. The contents were 
mixed by vortexing and then centrifuged at 4°C at15, 000 g for 15 min. The upper 
aqueous layer was transferred into another clean micro centrifuge tube. These steps 
were repeated with the above stated pheol:chloroform:isoamylalacohol mixture and then 
with chloroform:isoamylalacohol (24:1 ratio) mixture. To the final recovered aqueous 
layer, 0.5 ml absolute cold ethanol is added, incubated at -20°C for 15 min and then 
centrifuged at 15,000g for 15 min. The DNA pellet was washed with 0.5 ml of 70% 
ethanol. The final purified DNA pellet was air dried and resuspended in 20 μl of TE 
buffer and stored at -20°C until further use. 
             Ligation reactions 
 
The  ligation reactions included approximately 25 ng of linearized purified plasmid 
vector DNA, 5 to10 molar excess of insert DNA, 1x ligation buffer, 5 units of T4 DNA 
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ligase (Promega Corporation, Madison, WI) in a 20 μl reaction volume. The ligation 
reactions were carried out by incubating the contents at 15°C for 16 h. Following the 
ligation, 1 μl of ligation mix was used for transformation by chemical method (described 
below). Alternatively for further use, the DNA was purified by phenol: chloroform: 
isoamyl alcohol method described above. 
Preparation of Luria-Bertani (LB) media and LB agarose plates 
 
To prepare 1 lit of LB liquid medium, 15 g tryptone, 10 g of yeast extract and 10 g of 
sodium chloride were dissolved in 1 liter of double distilled water and pH of the solution 
was adjusted to 7.0 by adding drop by drop of 10N NaOH. Then the medium was 
autoclaved at a liquid cycle. LB agar plate’s preparation included similar preparation as 
described above but with the addition of 15 grams of cell culture grade bacto-agar prior 
to autoclaving. After autoclaving, the LB agar medium was allowed to cool to nearly 
50°C and a desired concentration of appropriate antibiotic was added to the medium. 
Approximately 30 ml of medium each was poured into sterile agar plates. After 
solidification of the agar medium, the plates were wrapped with parafilm and stored at 
4°C for subsequent use. 
Preparation of E. coli cells for use in chemical transformation methods 
  
The E. coli strains utilized to prepare competent cells were Top 10 cells (Invitrogen 
Technologies, Carlsbad, CA). To prepare chemical competent cells, an E. coli colony 
from a streaked plate was cultured in 3 ml of LB medium overnight in a 37°C incubator, 
shaking at 250 rpm. Subsequently, E. coli culture was re-inoculated into 100 ml LB 
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medium and grown in a 37°C incubator. After the cells were grown to 0.4 optical density 
(measured at 600 nm in a spectrophotometer), the cultures were harvested by 
centrifuging at 2,500 g for 5 min at 4°C. The cell pellet was resuspended in 10 ml of 
freshly prepared 10 mM Tris-HCl (pH, 7.5) and 50 mM CaCl2, and incubated on ice for 
30 min. The cultures were centrifuged again at 2,500g for 5 min at 4°C and the pellet 
was suspended in 2 ml of 10 mM Tris-HCl (pH, 7.5) and 50 mM CaCl2 and stored first 
in liquid nitrogen and subsequently at -80°C. 
Transformation protocol 
 
Transformation of ligated products into E. coli cells was performed by a chemical 
method (CaCl2). Typically, 200 μl of chemical competent E. coli cells were mixed with 
50 μl of 100 mM CaCl2 and 49 μl of sterile water. One μl of ligation products were added 
to this suspension and mixed by gentle tapping of the tube. The contents were then 
incubated in ice for 15 min, followed by a heat shock at 42°C for 2 min. The cells were 
then incubated at room temperature for 10 min; subsequently 1 ml of LB medium was 
added and transferred to a 37°C shaker incubator set at 200 rpm for 1h. Cultures were 
then recovered by centrifugation at 2,500 g for 5 min at 4°C, resuspended in about 200 
ul of the media (typically, resuspended in residual media remained after decanting the 
LB media after centrifugation) and plated on to LB agarose plates containing 
appropriate antibiotics and chemicals for selecting transformants containing plasmids 
with recombinant inserts. The culture was uniformly dispersed onto the agar plates 
using a glass rod spreader. Then the plates were incubated overnight in a 37°C 
incubator overnight. 
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              Selection of recombinant clones 
 
The presence of transformants on agarose plates containing the transformed cultures 
(described above) was assessed by comparing plates containing appropriate controls 
(ligation controls, no transformation controls). Transformants containing plasmids with 
inserts were selected, transferred to liquid LB media and  inoculated with an appropriate 
antibiotic and were grown overnight at 37°C in a shaker incubator for use in isolating 
plasmid DNAs. 
Plasmid DNA isolation 
 
From overnight grown E. coli cultures, plasmid DNA was isolated by following boiling 
preparation method. To isolate plasmid DNA, 1.5 ml of overnight grown bacterial 
cultures were transferred to a 2 ml micro centrifuge tube and centrifuged 12,000 g for 5 
min. The supernatant was aspirated out carefully and cell pellet was resuspended in 0.4 
ml plasmid lysis buffer (10 mM Tris-HCl pH 8.0, 0.1 M NaCl, 1mM EDTA, and 5% v/v 
Triton X-100) with the help of a tooth pick. Twenty five micro liters of freshly prepared 
lysozyme (10 mg/ml) was added. (Lysozyme was prepared by dissolving 10 mg of 
lysozyme powder in 1 ml of 10 mM Tris-HCl buffer (pH, 8.0) to get a final concentration 
of 10 mg/ml.) The contents of the tube were vertexed to mix, placed in a boiling water 
bath exactly for 40 sec, and centrifuged at 12,000 g for 15 min at 4°C. The pellet 
containing cell debris was removed with the help of a tooth pick. Four hundred and 
twenty μl of 100%, cold (-20°C), isopropanol was added to the supernatant and mixed 
by vertexing, incubated at room temperature for 5 min and centrifuged at 12,000 g for 
15 min to recover plasmid DNA. Supernatant was discarded and the DNA pellet was 
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washed with 70% ethanol and dried using a speed-vac system (Labconco Centrivap 
Concentrator, Kansas City, MO) typically for about 5 min. Final DNA pellets were 
resuspended in 100 μl of TE buffer and contaminating bacterial RNA was digested by 
treating with 1 μl of RNase A (1 mg/ml) at 37°C for 5 min. The presence and quality of 
the plasmid DNA was checked by agarose gel electrophoresis. 
Isolation of genomic DNA 
 
Genomic DNA was isolated from wild-type or from the transformed E. chaffeensis 
organisms. Genomic DNA of E. chaffeensis grown in macrophage cultures was isolated 
by sodium dodecyl sulfate-proteinase K-phenol, chloroform-isoamyl-alcohol method 
(336). Briefly, 1.5 ml of E. chaffeensis cultures were harvested by centrifugation at 
12,000 g for 15 min and the cell pellet was resuspended in 0.5 ml of DNA extraction 
buffer (10 Mm Tris-HCl pH 8.0, 0.1 M EDTA, and 0.5% SDS) (Vijay, I think that the DNA 
extraction buffer also contains NaCl; please verify) containing 0.5 mg/ml proteinase K 
(Sigma Chemical Co., St. Louis, MO). The contents were mixed by vertexing and 
incubated for 6 h at 56°C. Phenol:chloroform:isoamyl alcohol extraction method (as 
described above) was used to remove proteinecious material and the final purified DNA 
was recovered by ethanol precipitation methods as described previously. DNA pellets 
were air dried and resuspended in 100 of TE buffer. To remove the contaminating RNA, 
the DNAs were treated with 1 μl RNase A (10 mg/ml) at room temperature for 10 min. 
The DNAs were stored at -20°C until use. 
              Agarose gel electrophoresis 
 
26 
 
Plasmid DNA, restriction digestion products or PCR products were analyzed by 
resolving them on a 0.9% agarose gels by subjecting to electrophoresis. The agarose 
gels were prepared by dissolving agarose powder in 1x TAE buffer (40 mM Tris-acetate, 
1 mM EDTA; final pH 8.0) containing 0.1 μg/ml of ethidium bromide. The contents were 
poured on a gel holding device and were allowed to solidify at room temperature. The 
gel was placed in an electrophoresis chamber containing 1X TAE buffer with 0.1 μg/ml 
of ethidium bromide. About 5 μl of DNA containing 1 x gel loading buffer was loaded into 
the wells. Molecular weights markers were also loaded in a separate well and resolved 
to help in determining the approximate molecular weight of the unknown DNA fragments 
resolved. The DNA was subjected to electrophoresis in agarose gels at 70 V for 60-90 
minutes and was visualized under UV illumination. The images are captured using 
Kodak gel imaging system. 
           Preparation of E. chaffeensis for transformation experiments 
           In vitro cultivation of E. chaffeensis  
The Arkansas isolate of E. chaffeensis was cultivated in vitro in the canine 
macrophage cell line DH82 at 37°C, by following the protocols established before [87].  
            Purification of E. chaffeensis 
E. chaffeensis infected macrophage cultures were harvested when the infectivity 
reached to 80-90 % in nearly 100% confluent flasks.  Infection was assessed by 
microscopic examination of polychromatic stained cytospin slides.  About 25 ml of 
infected culture was collected into a 50 ml sterile falcon tube and centrifuged at 15,000 
g for 15 min.  The supernatant was discarded and the pellet is resuspended in 10 ml of 
0.25 M ice cold sucrose solution.  The cells were lysed by adding grit and vortexing 
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twice for 30 sec.  The lysed cell suspension was transferred to a new sterile tube free of 
glass beads and centrifuged at 100 g for 10 min. The supernatant was carefully 
collected and transferred to a new tube and centrifuged at 15,000 g for 15 min to collect 
cell-free Ehrlichia organisms. At the end of centrifugation, supernatant was discarded 
and the cell-free bacteria pellet was resuspended in 10 ml of 0.25 M ice cold sucrose.  
The centrifugation step was repeated one more time and the final E. chaffeensis 
organism pellet was resuspended in 0.6-1 ml of 0.25 M sucrose solution. Also in some 
experiments cell free cells were made by passing the culture through bent needle. 
Preparation of plasmid DNA for electroporation 
 
E. coli cultures containing the transposon plasmids were grown in 120 ml LB media with 
respective antibiotics) for about 16 h. The cultures were used to isolate plasmid DNA by 
following the protocols outlined by EndoFree Plasmid Purification Kit (QIANGEN, CA). 
Briefly, the culture was centrifuged at 6,000 g for 15 min at 4°C, and then the 
supernatant was discarded. The pellet was resuspended in 10 ml buffer P1 (QIANGEN, 
CA), and mixed thoroughly with 10 ml buffer P2 (QIANGEN, CA), followed by incubating 
at room temperature 24°C for 5 min. During the incubation, the QIAfilter Cartridge was 
prepared (screw the cap onto the outlet nozzle of the QIAfilter Maxi Catridge and place 
the QIAfilter Cartridge in a convenient tube). Ten ml chilled buffer P3 (QIANGEN, CA) 
was added to the lysate, and mixed immediately and thoroughly by vigorously inverting 
for 6 times (do not incubate the lysate on ice). The lysate was poured into the barrel of 
the QIAfilter Cartridge, and was incubated at room temperature for 10 min. The cap 
from the QIAfilter Catridge outlet nozzle was removed. The plunger was gently inserted 
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into the QIAfilter Maxi Cartridge and the cell lysate was filtered into a 50 ml tube. Two 
and half  ml buffer ER (QIANGEN, CA) was added to the filtered lysate, mixed by 
inverting the tube approximately 10 times and incubated on ice for 30 min. A QIAGEN-
tip 500 was equilibrated by applying 10 ml buffer QBT (QIANGEN, CA), and allowing 
the column empty by gravity flow. The filtered lysate was applied to the QIAGEN-tip. 
The QIAGEN-tip was washed with 30 ml buffer QC (QIANGEN, CA) for 2 times. 
Plasmid DNA was eluted with 15 ml buffer QN (QIANGEN, CA) and precipitated by 
adding 10.5 ml room-temperature isopropanol, followed by mixing and centrifuging 
immediately at 15,000 g for 30 min at 4℃. The supernatant was carefully decanted. 
DNA pellet was washed with 5 ml of endotoxin-free 70% ethanol stored at room 
temperature (40 ml of 96-100% ethanol was added to the endotoxinfree water supplied 
with the kit) and centrifuged at 15,000 g for 10 min. The supernatant was carefully 
decanted without disturbing the pellet. The pellet was air-dried for 10 minutes and the 
DNA was dissolved in 100 µl of endotoxin-free TE buffer (QIANGEN, CA). The purified 
plasmid was stored at -80℃ for later use. 
           Transformation of E. chaffeensis in DH 82 macrophage cells 
 
E. chaffeensis cultures were grown in macrophage cell line, DH 82, and when infection 
reached to > 90%, cultures were harvested by spinning at 15, 000 g for 15 min at 4°C. 
To the pellet, 10 ml of ice-cold 0.25 M sucrose solution was added and vortexed to 
resuspend the culture. The host cells were broken by passing through 27.5 gauge 
bended needles for 4 times, and centrifuged at 200 g for 10 min at 4°C to pellet the cell 
debris. The supernatant containing Ehrlichia organisms was filtered through 2.7 µm filter 
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and spun at 15,000 g for 15 min at 4°C to collect the cell free bacteria. The pellet was 
washed twice with ice cold sucrose solution (0.25 M) 10 ml and the final pellet was 
resuspended in 0.6-1 ml of 0.25 M ice-cold sucrose. The final sucrose solution varied 
depending on the estimated number of organisms and 100 µl each of the purified E. 
chaffeensis suspension was used for transformation expressions. One µl plasmid DNA 
and purified Ehrlichia organisms were mixed in an electroporating cuvette for use in 
electroporation. The electroporation was performed twice at 1800 V. To serve as a 
control, 100 µl of cell-free bacteria were also electroporated by giving double shock at 
1800 V. The electroporated cells were transferred into T 25 cm flask of DH82 cells 
having 80% confluency (5 ml culture volume). The culture flasks were incubated at 37°C 
for overnight. Fraction of cultures from each flask (1.5 ml each) were harvested at 
different times post transformation (6 h, 12 h, 24 h, 48 h and 6 days and till 2months in 
some experiments) for use in DNA isolation and analysis. To the remaining culture, 
media is replaced every three or four days and E. chaffeensis infection was monitored 
for up to two months. The culture flasks were maintained with an appropriate antibiotic, 
starting from the day 3 following transformation.   
            Genomic DNA isolation  
 
The genomic DNA was isolated at many time points using the phenol and proteinase k 
method described in above methods. 
            Methods for monitoring transformants 
The culture derived DNA was used to perform PCR and Southern blot analysis with 
specific probes.  
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            Southern Blotting 
 
The PCR products were resolved on a 0.9% agarose gel by subjecting to 40 V for 6 h 
and the resolved DNA was transferred to a nylon membrane. The prehybridization 
solution was prepared which contained 6 X SSC, 10 mm sodium phosphate buffer pH 
6.8, 1 mm EDTA pH 8.0, 10 X Denhard’s, 100 µg/ml sonicated and denatured salmon 
sperm DNA, and 0.5% SDS. The membrane was prehybridized for 2 h at 68℃. The 32P-
labeled DNA probes were synthesized by using Primer-It II Random primer labeling kit 
(Stratagene, Carlsbad, CA). After 14 h of hybridization at 68℃, the membrane was 
washed with 50 ml wash buffers; once with 6 X SSC containing 0.1% SDS followed by 
one wash with 2 X SSC having 0.1 % SDS, one wash with 1 X SSC containing 0.1% 
SDS, and a final wash was performed with 0.1 X SSC and 0.1% SDS.  The nylon 
membrane was then exposed to an X-ray film at -70℃ by using an intensifying screen.   
           Semi random, two step PCR (ST-PCR)  
 
The ST-PCR method was described by Chun et al [85]. In the ST-PCR one primer 
contained sequence complimentary to the transposon insertion sequence and the 
second primer contained a 20-nucleotide specific sequence followed by a ten bases of 
degenerate sequence and a specific five nucleotide sequence GATAT. A subset of 
these primers anneal to an unknown DNA sequence near the transposable element. 
These primers will allow the initial amplification. The second pair of primers is designed 
to be specific for the amplicons produced in the first round. One primer is 
complementary to the known transposon sequence and the other primer is specific to 
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the 20-nucleotide sequence in the semi random primer.  The PCR strategy was 
illustrated in Figure 3.6.   
Genomic DNA isolated from host cell free E. chaffeensis mutants was used in all ST-
PCRs as templates.  In particular, the cultured organisms were purified by following 
renografin purification method to eliminate host cells and contaminating host genomic 
DNA.  Briefly, the mutant E. chaffeensis infected DH82 cultures were harvested when 
the infection level reached to ~ 90%. The cells were harvested and pelleted by spinning 
at 12,000 g. The pellet was suspended in 1x PBS and was passed 4-5 times through a 
bent needle to break the DH82 cells for releasing E. chaffeensis organisms. The 
suspension was then filtered through 2.7 um and 1.6 um filters to recover host cell free 
E. chaffeensis organisms were suspended in 1 x PBS. For the renografin gradient, 
different concentrations of renografin (34%, 44% 54%) were prepared by diluting the 
stock renografin in 1x PBS. Gradients were made in a clear ultracentrifuge tubes, the E. 
chaffeensis organisms in PBS were layered above the 34% renografin layer. The 
gradient tubes containing the organisms were centrifuged at 30,000 rpm for 1 h 
Ehrlichia organisms remain at the interfaces between the PBS and 34% renografin; 
34% and 44% renografin; 44% and 54% renografin due to differences in the densities of 
the organisms. Bacterial fractions from all three interfaces were collected, pooled and 
diluted in PBS and centrifuged at 25,000 rpm for 30 min to recover the organisms. The 
resulted Ehrlichia pellet was used to isolate genomic DNA by phenol/chloroform/isoamyl 
alcohol extraction method for use as the template for the ST-PCR reactions.  
In the first round of ST-PCRs, 10 ng each of host cell-free Ehrlichia genomic DNA was 
used in 20 ul reaction mixture containing 50 mM KCl, 10 mM Tris HCl (pH 8.3 ), 200 
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ug/ml gelatin, 3 mM MgCl2 , 200 uM of dNTPs, 20 pmol each of PCR primers. (Primer 
set 1 and 2 for first reaction; 3 and 4 for 2nd reaction.) ST-PCRs were performed using 
BIORAD Real time PCR system. The products from the first PCR were resolved on an 
agarose gel and subsequently the products were diluted 1:100 in TE buffer and one 
micro liter each was used as the template for the second round of PCR by following the 
conditions optimized for the assays.   
 
 
 
Table 1 ST-PCR primers  
                        SET  PRIMERS  
                         1 RRG 1260 (random for 1st round ) 
                         2 RRG 1194, RRG 1259, RRG 1264 
                         3 RRG 1261(random for 2nd round) 
                         4       RRG 1258, RRG1194, RRG1202 
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Table 2ST –PCR first round settings  
 
Table 3: ST-PCR second round settings 
1 940C, 30 seconds 
2 650C, 30 seconds 
3 720C, 3minutes 
GOTO 1, 29 x more 
4 40C 
5 END 
1 940C , 2min  
2 940C, 30 seconds 
3 Initial tem = 420C, 30 seconds 
-1.0C for each subsequent cycle  
4 720C, 3 minutes  
5 GOTO 2  5x more 
6 940C, 30 seconds 
650C, 30 seconds 
720C, 3 minutes 
 
7  GOTO 6  24x more  
8 40C , end  
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             DNA sequencing 
   The products from the ST-PCR reactions were sequenced on ceq sequencer. The 
protocols for sequencing analysis were followed as described in the CEQ 2000 Dye 
Terminator Cycle Sequencing  with Quick Start Kit manual (Beckman Coulter, CA). 
BLAST search analysis 
 
 The sequences obtained from the ST-PCR products were searched against the E. 
chaffeensis genome available at NCBI database by performing BLAST search program 
available at the NCBI website. 
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            Transposon mutagenesis of E. chaffeensis  
 
Recent studies have shown that Himar 1 transposase system is useful in creating 
insertion mutations in both Gram positive and Gram negative bacteria [81, 83]   This 
method is also used in creating mutations in intraphagosomal, pathogenic bacteria such 
as A. phagocytophilum, A. marginale and C. burnetti [79, 83] Our research team 
collaborated with Dr. Ulrike Munderloh at University of Minnesota in creating random 
mutations in E. chaffeensis by utilizing transposon- mutagenesis method [88]. The 
Himar 1 transposon plasmid constructs previously used for mutagenesis of A. 
phagocytophilum were modified to create a single plasmid system. The plasmid 
construct contained both transposase coding sequence and transposon insertion 
segment with transposase-specific recognizable inverted repeats are engineered into 
single plasmid. The transposable element contained either the GFPuv or mCherry 
expression cassette, as well as the spectinomycin resistance gene cassette (aad gene) 
and their expression is driven by A. marginale transcription regulator promoter (Amtr). 
Similarly, the transposase expression is driven by the Amtr promoter. Three 
independent experiments were performed; one with the mCherry plasmid and two with 
GFPuv plasmid (plasmids are illustrated in Figures 3.1 and 3.2). The transformation 
experiments were performed in E. chaffeensis organisms recovered from ISE6 tick cell 
cultures as described earlier [81]. The transformants were propagated in initially in 
ISE6-tick cells to select mutants conferring resistance to spectinomycin and 
streptomycin (100ug/ml each) and then transferred to DH82 cells while maintaining the 
antibiotics in the culture media. The cultures were also observed microscopically for the 
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expression of mCherry or GFPuv.  My research involved mapping the genomic sites 
from the mCherry mutants and the GFP mutants from one experiment each.   
              Southern blot analysis 
 
The transposon insertions in the mutants were verified by performing Southern blot 
analysis (Figures 3.3, 3.4 and 3.5). Genomic DNA isolated from the transformed 
cultures of E. chaffeensis was digested with restriction enzymes which do not have 
recognition sites to generate single DNA fragments recognizable when probed with the 
probe used for DNA blot hybridization. About 100 ng each of DNA isolated from the 
transformed cultures was digested with the following restriction enzyme; Hind III, Bgl II, 
Spe I/Nde I, Bsrg I or EcoR V/Bgl II. Digested DNAs were resolved on an agarose gel, 
transferred to a nylon membrane, and probed with the 32p-labeled aad gene segment. 
Multiple restriction digested DNA segments were recognized by the probe in the DNAs 
of mutants derived from the transposon constructs containing mCherry and GFPuv 
(Figure 3.1 and 3.2).  
Southern blot analysis was also performed using the mutants’ genomic DNA isolated at 
two different time points following their growth to assess the stability of the mutants in 
culture. The Sothern blot data revealed variations in the DNA fragments recognized by 
the aad probe suggesting that the genomic DNA from the cultured mutants represented 
pool of multiple mutants and that the mutants’ growth is variable during their growth in 
culture. 
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             Mapping of the transposon insertion sites using ST-PCR 
 
For mapping the exact location of the transposon insertions in the E. chaffeensis 
chromosome, we used the ST-PCR method described by [85] (Figure 3.7 has a cartoon 
showing the ST-PCR strategy). Three independent ST-PCR experiments were 
performed using different primer combinations (Figures 3.7-3.13). The final products 
from the 2nd round ST-PCR were resolved on an agarose gel and the entire strong and 
discrete DNA bands were recovered from the gels and the DNA were purified. The 
DNAs were subjected to sequence analysis. The resulting sequences were compared 
with the E. chaffeensis genome data to identify the location of the insertion sites. The 
alignment data identifying the insertion sites are shown in Figure 3.14. 
The analysis aided in the identification of four transposon insertion locations in 
the genome. Further, it verified four other insertion sites previously identified by rescue 
cloning method. Together, the ST-PCR method was valuable in confirming the location 
of transposon insertions at 8 genomic sites within the E. chaffeensis chromosome. Six 
of the 8 transposon insertions were present within the non-coding regions of the 
genome and the remaining two insertions were present within the coding regions of two 
hypothetical proteins (Ech_0379 and Ech_0601) (Figure 3.14).   
 
Transposon insertion regions 
MCherry mutant 
1. Inside non coding region between the genes ECH_0230 and ECH_0231 
2. Inside non coding region between the genes ECH_0284 and ECH_0285 
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3. Inside non coding region between the genes  ECH_0479 and ECH_0480 
4. Inside non coding region between the genes ECH_0490 and ECH_0492 
5. Within the coding sequence of the gene ECH_0379  
GFPuv mutant  
1. Inside non coding region between the genes ECH_0202 and ECH_0203 
2. Inside non coding region between the genes ECH_0760 and ECH_0761 
3. Within  the coding sequence of the gene ECH_0601 
 
Some of the BLAST program alignments performed in mapping the insertion 
mutations  
 
 Mapping Insertion at 478108 (in between Ech_0490 (forward) and Ech_0492 (complement)) as 
478107-ITR-AmTr-mCherry-Spec-ITR-478108 
 
Sequence given below is derived from ST-PCR second round amplicon  
  
TGCTTTACGCGAGGGTGGGCGGATATCAGACTTATAAAACGTATTAAGAAATCTTAC
AAGCATTTATAATAAAATAATATATTAGTCGATACCATTGTAAAAATGGCTCAACGT
TTACCTTTTTACCTCAACCTCACATAATATATAATCAGATTTATATCTAGATTCTATT
TTTCTATTAAATATACAAAAAATTTACTTCTAACAGGTTGGCTGATAAGTCCCCGGT
CTAAGCTTGCATGCCTGCAGGTCGACTCTAGATTATTTGCCGACTACCTTGGTGATCT
CGCCTTTCACGTAGTGAACAAATTCTTCCAACATGA 
 
 
The sequence was blasted against the E. chaffeensis str Arkasnas genome using the 
BLAST algorithm. The alignment shows that part of the sequence is complimentary to 
the E. Chaffeensis genome and other part is complimentary to the transposon insertion 
sequence. This gives the data regarding the point of insertion and the exact location of 
the insertion within the genome  
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Alignment  
> gb|CP000236.1|  Ehrlichia chaffeensis str. Arkansas, complete genome 
Length=1176248 
 
 
                                                         Sort alignments for this subject 
sequence by: 
                                                           E value  Score  Percent identity 
                                                           Query start position  Subject start 
position 
 Features flanking this part of subject sequence: 
   165 bp at 5' side: lipoic acid synthetase  (Ech_0490: 477049-477942) 
   253 bp at 3' side: putative phosphate ABC transporter, permease protein 
(Ech_0492:478543::479811) 
 
 Score =  327 bits (362),  Expect = 8e-91 
 Identities = 183/184 (99%), Gaps = 0/184 (0%) 
 Strand=Plus/Minus 
 
Query  22      GATATCAGACTTATAAAACGTATTAAGAAATCTTACAAGCATTTATAATAAAATAATATA  81 
               ||||||| |||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  478290  GATATCAAACTTATAAAACGTATTAAGAAATCTTACAAGCATTTATAATAAAATAATATA  478231 
 
Query  82      TTAGTCGATACCATTGTAAAAATGGCTCAACGTTTACCTTTTTACCTCAACCTCACATAA  141 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  478230  TTAGTCGATACCATTGTAAAAATGGCTCAACGTTTACCTTTTTACCTCAACCTCACATAA  478171 
 
Query  142     TATATAATCAGATTTATATCTAGATTCTATTTTTCTATTAAATATACAAAAAATTTACTT  201 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  478170  TATATAATCAGATTTATATCTAGATTCTATTTTTCTATTAAATATACAAAAAATTTACTT  478111 
 
Query  202     CTAA  205 
               |||| 
Sbjct  478110  CTAA  478107 
 
The above sequence was matched with the E. chaffeensis genome  
 
 
Sequence matched with transposon sequence (ITR-AmTr-cherry-Spec-ITR seq) 
 
Score =  212 bits (234),  Expect = 7e-59 
 Identities = 117/117 (100%), Gaps = 0/117 (0%) 
 Strand=Plus/Minus 
 
Query  203   TAACAGGTTGGCTGATAAGTCCCCGGTCTAAGCTTGCATGCCTGCAGGTCGACTCTAGAT  262 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1843  TAACAGGTTGGCTGATAAGTCCCCGGTCTAAGCTTGCATGCCTGCAGGTCGACTCTAGAT  1784 
 
Query  263   TATTTGCCGACTACCTTGGTGATCTCGCCTTTCACGTAGTGAACAAATTCTTCCAAC  319 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1783  TATTTGCCGACTACCTTGGTGATCTCGCCTTTCACGTAGTGAACAAATTCTTCCAAC  1727 
 
 
 Score = 53.6 bits (58),  Expect = 4e-11 
 Identities = 29/29 (100%), Gaps = 0/29 (0%) 
 Strand=Plus/Plus 
 
Query  203  TAACAGGTTGGCTGATAAGTCCCCGGTCT  231 
            ||||||||||||||||||||||||||||| 
Sbjct  1    TAACAGGTTGGCTGATAAGTCCCCGGTCT  29 
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LOCUS       CP000236                2763 bp    DNA     linear   BCT 11-MAR-
2010 
DEFINITION  Ehrlichia chaffeensis str. Arkansas, complete genome. 
ACCESSION   CP000236 REGION: 477049..479811 
FEATURES             Location/Qualifiers 
     source          1..2763 
      
The italicized sequences are both upstream and downstream of the open reading 
frame. The arrow shows the exact position of the transposon sequence insertion. 
 
 
        1 atgagaagta aacctgattg gttaaaagtt aagatgccta caggggatac tttttatcaa 
       61 gttcgcaatt taatgaaatt gtataaatta aatactgtgt gtgaagaagc agcttgtccc 
      121 aacattggtg agtgttggaa taaaagacat gcaacagtaa tgattttagg ttctacatgt 
      181 actagagcat gtgcattttg taatgttgtt tctggaattc cagataaact ggatcctcat 
      241 gagcctcaaa acttagctaa ggctgttggt ttacttaaac ttgagcacgt tgttattaca 
      301 tctgtagaca gggatgactt ggaagatggt ggatctggac attttgtaga gtgtatagaa 
      361 gaaatacgaa aaaacgatca gaatgttact attgaagtat taactccaga ttttttgaat 
      421 aaacatggtg caattgaaaa ggttgctgat gctgctcctg atgtttacaa tcataatata 
      481 gaaactgttc caaggttgta tgcaaaaatt agaccaaaag cacgttactt tcattctctt 
      541 tatttgttaa aaacagttaa atataaaaat cctaaagtat ttactaaatc tggaattatg 
      601 gtaggattgg gtgaaacaaa agaagaaata tatcaagtaa tgaatgattt aagatctgcg 
      661 gatgttgatt ttataacgat tggtcaatat ttgcagccta ctcctaagca tgctgcagtt 
      721 gataggtatg taactcctga agaatttgat cattacaagt atgttgcata ctctaaaggg 
      781 tttttaatgg ttgcgtcggg ccctttagta aggtcttcat accatgctgg agaggatttt 
      841 caaaggttaa agaaaaatcg tgctgctatg ttcatgcatg ctaaaagcaa ttagaattaa 
      901 catggtagtt aatatttttt agaagtttga atgtttatac cagaagggtt tttcattagt 
      961 tttatatgat atttaatttt ttagatagtt aatcggtagt gtagttggtt gtaatctgag 
 
 
     1021 gaaagttttt gtgattgaga gaaagtaggc tatacata ttagaagtaaat tttttgtata 
     1081 tttaatagaa aaatagaatc tagatataaa tctgattata tattatgtga ggttgaggta 
     1141 aaaaggtaaa cgttgagcca tttttacaat ggtatcgact aatatattat tttattataa 
     1201 atgcttgtaa gatttcttaa tacgttttat aagtttgata tcgcacttat agctcagtgg 
     1261 atagagcgtt accctccgga ggtaaaagtc gcaggttcaa atcctgctaa gtgcacttat 
     1321 tttttatgtt attataaaat attaatgtgg agcaacaata ttgttgatgt tatctctttt 
     1381 ttcatagttt ggtaatgata gtttagttaa tgttgcttta tgattattaa tatatatggg 
     1441 gaattattat ttgtaatgta ttaattgaag agtgaatcat tgaatttaag tattttaaaa 
     1501 aataaaatga tcaaactttt tccttataaa agttactata agatttagaa ttaataacat 
     1561 taaaagtaga gctactatag caattgcagc taattggata aattcaatat gtggattact 
     1621 tgcccacata tatatttgta caggtaatac agttgttgga tcgagaaaat cctttggaat 
     1681 atcaactatg aatgctacca tcccaatcat tattaacgga gaagattcac ctaagattct 
     1741 tgcaatactt aaaatagcac cttgcatgat actaggtaat gctattggaa atgagtgatg 
     1801 tagaattacc tgcatatttg atgctcctag tgagaaagct gcatctttta cggatggtgg 
     1861 cactgctgca aatgcttgtt ttgtagatgt taccaaattt ggtaacatca ttaatgatag 
     1921 agtcatacca cctataagtg ctgatgaacg tggtatatca aaaatattga tgtatattgc 
     1981 taaccctaaa atgccaaata ttattgacgg tacagatgca agatttgtta tgctgatttc 
     2041 gataatagaa gatattttat tttttggtat gagctcactt aaacatatgc cggatgtgat 
     2101 acctataggt aatgcgaatg ttaaacatat aattattgta aacatggatc ctattagtga 
     2161 gccaagaatc ccagtatttt caggagatct agagttatat tttgtaaaca gtgcgtcatt 
     2221 aaatgatact tttatcctgt tttcattttg taattttgca ataacttttt gatatattgc 
Site of Insertion 
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     2281 atgatttatg tttttgtttt tgatagcttt attaaatgta gtggaagatt gaaaccatat 
     2341 gttgaattta gtggattttg gattcttaag tagaaaatct gctaaattat gatgagcagt 
     2401 atcatttatt atattataaa tgatttttct attgtcagga tttgaaagat ctataacatt 
     2461 tgaaaatagt tcctctaagg attgatgaat aaaatatatt agattgtttc tcaatgttag 
     2521 tttatcttgt tgttctatag tatcattatt gattgtaatt gataataaaa tttttgttgt 
     2581 tgttagtgca ttatatccat tgttaacgat acttcctaaa attataaaaa gtatacctaa 
     2641 ggaactaaca agtgcagtca ttgataggat tgataagata cgatccttcc tattttttaa 
     2701 ggatatacgg gaagcaatat gacgatactt tagtaattta cctaattttt ttcgtatgtg 
     2761 cat 
 
 
Mapping of Ech_0202 
Sequence obtained from ST-PCR  
  
GCGAGAGCGTGAGGCGGTATATAAAGATTTAAAGCGAATACAGTAATGGTATTAGT
TTTTCGTAAAATATGAGAGGAGCATGTTCAGGGTGTCCAAGTGCCTCAATTACTCTG
AAAAGAAGGTATATATAATATGTTGAGCTATTATATTCCGGATATACAAGGTGTAGA
GAGTATTCAGTAGAAATAGAATATATTAGTTTTGCTGTTGTGTTGGAAAGTACTTTTT
AAGTTTTTAAGTCTATAGAAATTATCTGTAACAGGTTGGCTGATAAGTCCCCGGTCT
AAGCTTGCATGCCTGCAGGTCGACTCTAGATTATTTGCCGACTACCTTGGTGATCTC
GCCTTTCACGTAGTGAACAAATTCTTCTCTTTTTCATGAATTAAAACAAATACTTTTT
TTTTAGA 
 
Blasted against E. chaffeensis genome  
> gb|CP000236.1|  Ehrlichia chaffeensis str. Arkansas, complete genome 
Length=1176248 
 
 
 
 Score =  363 bits (402),  Expect = 1e-101 
 Identities = 230/240 (96%), Gaps = 8/240 (3%) 
 Strand=Plus/Plus 
 
Query  19      ATATAAAGATTTAAAGCGAATACAGTAATGGTATTAGTTTTTCGTAAAATATGAGAGGAG  78 
               |||||||| |||||||   |||||||||||||||| |||||| ||||||| ||||||||| 
Sbjct  193038  ATATAAAG-TTTAAAGG--ATACAGTAATGGTATT-GTTTTT-GTAAAAT-TGAGAGGAG  193091 
 
Query  79      CATGTTCAGGGTGTCCAAGTGCCTCAATTACTCTGAAAAGAAGGTATATATAATATGTTG  138 
               |||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||| 
Sbjct  193092  CATGTTCAGGGTGTCCAAGTGCCTCAATTACTCTGAAA-GAAGGTATATATAATATGTTG  193150 
 
Query  139     AGCTATTATATTCCGGATATACAAGGTGTAGAGAGTATTCAGTAGAAATAGAATATATTA  198 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  193151  AGCTATTATATTCCGGATATACAAGGTGTAGAGAGTATTCAGTAGAAATAGAATATATTA  193210 
 
Query  199     GTTTTGCTGTTGTGTTGGAAAGTACTTTTTAAGTTTTTAAGTCTATAGAAATTATCTGTA  258 
               ||||||||||||||||||||||||||||||||||||||||||||||| | |||||||||| 
Sbjct  193211  GTTTTGCTGTTGTGTTGGAAAGTACTTTTTAAGTTTTTAAGTCTATA-AGATTATCTGTA  193269 
 
193269-ITR-Spec-GFP-AmTr-ITR-193270 
Sequence matched with transposon sequence ( to ITR-AmTr-cherry-Spec-ITR seq) 
 
Query  257   TAACAGGTTGGCTGATAAGTCCCCGGTCTAAGCTTGCATGCCTGCAGGTCGACTCTAGAT  316 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1843  TAACAGGTTGGCTGATAAGTCCCCGGTCTAAGCTTGCATGCCTGCAGGTCGACTCTAGAT  1784 
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Query  317   TATTTGCCGACTACCTTGGTGATCTCGCCTTTCACGTAGTGAACAAATTCTTC  369 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1783  TATTTGCCGACTACCTTGGTGATCTCGCCTTTCACGTAGTGAACAAATTCTTC  1731 
 
 
 Score = 53.6 bits (58),  Expect = 5e-11 
 Identities = 29/29 (100%), Gaps = 0/29 (0%) 
 Strand=Plus/Plus 
 
Query  257  TAACAGGTTGGCTGATAAGTCCCCGGTCT  285 
            ||||||||||||||||||||||||||||| 
Sbjct  1    TAACAGGTTGGCTGATAAGTCCCCGGTCT  29 
 
                      
  
Mapping of Ech-0480 
 
Sequence obtained from ST-PCR: 
ATATATATAATAATATGTTATAATTTAATTATATTGTATAATCATATGATAATATAGC
TTTTTGTTCTAATTTATATTCTAAAGTAACAGGTTGGCTGATAAGTCCCCGGTCTGAA
TTCGGCTCCTCCTAGAACGATCGCCGCATGCTAGCATAAAACGCGCGCACTAACAA
GTGCCCAGCCGCGCTGCCTCAAAAAATCTCCGGAAGTTTCCCGGATATTTATCGATG
ATTTTATTCTTTAATCTAGCATACCATTTACAGTTCCTATTATTACAACCATACATTA
AATAACTGTTGCATTAACATTATGTATGATTTATCCTAAGTTATCTGAGTAACATAA
GGGATAACCNCTAAATTTTTGTCTCNTTTCACCAACCCCCCAATTCGGGGCCGGG 
 
 
Blasted against the Ehrlichia chaffeensis str. Arkansas, complete genome 
 
 
Query  85   TAACAGGTTGGCTGATAAGTCCCCGGTCTGAATTCGGCTCCTCCTAGAACGATCGCCGCA  144 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TAACAGGTTGGCTGATAAGTCCCCGGTCTGAATTCGGCTCCTCCTAGAACGATCGCCGCA  60 
 
Query  145  TGCTAGCATAAAACGCGCGCACTAACAAGTGCCCAGCCGCGCTGCCTCAAAAAATCTCCG  204 
            |||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||| 
Sbjct  61   TGCTAGCATAAAACGCGCGCACTAACAAGTGCCCAG-CGCGCTGCCTCAAAAAATCTCCG  119 
 
Query  205  GAAGTTTCCCGGATATTTATCGATGATTTTATTCTTTAATCTAGCATACCATTTACAGTT  264 
            |||||||||||||||||||| |||||||||||| |||||||||||||||||||||||||| 
Sbjct  120  GAAGTTTCCCGGATATTTATTGATGATTTTATT-TTTAATCTAGCATACCATTTACAGTT  178 
 
Query  265  CCTATTATTACAACCATACATTAAATAACTGTTGCATTAACATTATGTATGATTTATCCT  324 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  179  -TTATTATTACAACCATACATTAAATAACTGTTGCATTAACATTATGTATGATTTATCCT  237 
 
Query  325  AAGTTATCTGAGTAACATAAGGGATA  350 
            |||||||||||||||||||||||||| 
Sbjct  238  AAGTTATCTGAGTAACATAAGGGATA  263 
 
 
Mapping of Ech 0760 
Sequence obtained form the second round ST-PCR DNA band 
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TCGTAAATGACAATGTAATGAGATATCAGCTAGATAGATGAAACACATGTGTGTAT
AACTATGAGTAATGAATATACATGATGATGATACAATAACTATCTAGCCGTGGTGTT
TATGTAATCTAGGATGAACTAATGATGACTGCTAGTGTGTATGATGATTATATACCA
TCAGTAAAATATGTAATAAAAATCAATAGACACAGGTCATCATGATATAAAAACTG
ATAATAGAACTAAGCCTCTAACAAAAACTCATATAAAATGTTGGTAACATATCAAA
ATTAAAAAACACTTCAAATCATGAAAGCATTAATAAAGTTTCTCTCAAATTATCACT
AACTAACAGGTTGGCTGATAAGTCCCCGGTCTGAATACGGCTCCTCCTAGAACGATC
GCCGCATGCTAGCATAAAACGCGCGCACTAACAAGTGCCCAGCGCGCTGCCTCAAA
AAATCTCCGGAAGTTTCCCGGATATTTATTGATGATTTTATTTTTAATCTAGCATACC
ATTTACAGTTTTATTATTACAACCATACATTAAATAACTGTTGCATTAACATTATGTA
TGATTTATCCTAAGTTATCTGAGTACATGGAGAAAAAAAAAGGAAAAAAAATTAAG
GGGTAAATGGAAAAANGGTAAATTAAAAAGGGTAAGGGGGGGGGTAAAAAAAAAT
AAAAAAAGGGAAAAAAGGGGGGAGTGGCCCAGAAAATAAAAAA 
> gb|CP000236.1|  Ehrlichia chaffeensis str. Arkansas, complete genome 
Length=1176248 
 
 
                                                         Sort alignments for 
this subject sequence by: 
                                                           E value  Score  
Percent identity 
                                                           Query start 
position  Subject start position 
 Features flanking this part of subject sequence: 
   80 bp at 5' side: RNA polymerase sigma factor RpoD 
   150 bp at 3' side: DNA primase 
 
 Score =  269 bits (298),  Expect = 4e-73 
 Identities = 211/236 (89%), Gaps = 16/236 (7%) 
 Strand=Plus/Plus 
 
Query  109     GTGTTTATGTAATCTAGGATGAACTAATGATGACTGCTAGTGTGTATGATGATTATATAC  168 
               |||||||| ||| || |||| ||||||||||   |  |||||| |||   ||||| | || 
Sbjct  768139  GTGTTTAT-TAA-CT-GGAT-AACTAATGATTTTT--TAGTGT-TATA--GATTAAA-AC  768188 
 
Query  169     CATCAGTAAAATATGTAATAAAAATCAATAGACACAGGTCATCATGATATAAAAACTGAT  228 
               ||||||||||||||  |||||||||||| |||||||  |||||||||||||||||||||| 
Sbjct  768189  CATCAGTAAAATAT--AATAAAAATCAA-AGACACAT-TCATCATGATATAAAAACTGAT  768244 
 
Query  229     AATAGAACTAAGCCTCTAACAAAAACTCATATAAAATGTTGGTAACATATCAAAATTAAA  288 
               || ||||||||| |||||||||||||||||||||  | |||||||||||||||||||||| 
Sbjct  768245  AA-AGAACTAAGTCTCTAACAAAAACTCATATAACTT-TTGGTAACATATCAAAATTAAA  768302 
 
Query  289     AAACACTTCAAATCATGAAAGCATTAATAAAGTTTCTCTCAAATTATCACTAACTA  344 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  768303  AAACACTTCAAATCATGAAAGCATTAATAAAGTTTCTCTCAAATTATCACTAACTA  768358 
 
Sequence matched with transposon sequence (  ITR-AmTr-Cherry-Spec-ITR) 
 
Query  343  TAACAGGTTGGCTGATAAGTCCCCGGTCTGAATACGGCTCCTCCTAGAACGATCGCCGCA  402 
            ||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||| 
Sbjct  1    TAACAGGTTGGCTGATAAGTCCCCGGTCTGAATTCGGCTCCTCCTAGAACGATCGCCGCA  60 
 
Query  403  TGCTAGCATAAAACGCGCGCACTAACAAGTGCCCAGCGCGCTGCCTCAAAAAATCTCCGG  462 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TGCTAGCATAAAACGCGCGCACTAACAAGTGCCCAGCGCGCTGCCTCAAAAAATCTCCGG  120 
 
Query  463  AAGTTTCCCGGATATTTATTGATGATTTTATTTTTAATCTAGCATACCATTTACAGTTTT  522 
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            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  AAGTTTCCCGGATATTTATTGATGATTTTATTTTTAATCTAGCATACCATTTACAGTTTT  180 
 
Query  523  ATTATTACAACCATACATTAAATAACTGTTGCATTAACATTATGTATGATTTATCCTAAG  582 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  ATTATTACAACCATACATTAAATAACTGTTGCATTAACATTATGTATGATTTATCCTAAG  240 
 
Query  583  TTATCTGAGTA  593 
            ||||||||||| 
Sbjct  241  TTATCTGAGTA  251 
 
 
 Score = 53.6 bits (58),  Expect = 1e-10 
 Identities = 29/29 (100%), Gaps = 0/29 (0%) 
 Strand=Plus/Minus 
 
Query  343   TAACAGGTTGGCTGATAAGTCCCCGGTCT  371 
             ||||||||||||||||||||||||||||| 
Sbjct  1837  TAACAGGTTGGCTGATAAGTCCCCGGTCT  1809 
 
Mapping of ECH-0379 
 
Sequence obtained from ST-PCR  
 
TGACCTTTTGAGTTATGACACGCTAGTGCATATCAAGTGTAAGCATGTAGTGGTATT
ATCTATATAATAAGTAATAGTATATTACTATCCTAATAGTAATATGGGGAGTATTAG
ATAAGCTTTGTTTTGATCTATGTATTTAGATCCTCAGGATTTTGTAACACAAGTTATA
CGATTCTAGTGCATGTTTTTAGCATCTTTATATTCGAATATACTTGGATCTTAGGTTT
AGTACAATTTCTTGATTAGAAATGATGATATCTTGTGCCACATTCAGACAACACTAA
TTGCTAAGTATAAGCTATTAAGCCTATAAGCATTAAGTGTAACATTATCGCAAGTCT
AGACTGGCATGGCATTATACCAGGGTTATGGCTTGATACAGTACCCCGGATCTAATG
CTTAGCGATGCCTGCAGAGTCGACTCTAGCATGTATGTATGCTCGACTACCTGTAGC
GTGATCTGCGCCATTGTACACGATAGTGTAACTAGACATTACTGTCCATACTTGGAT
TTCTGGCGGCCTGACGAAGGGGCCAAATGATGAATTCGTTTCATATGTTCAACAAAC
GAATAAACGCACTTGTCCTTATGCTTTCATATGGTATTCGAACTGGGACTCGACTAC
GTCGCGGCCTGGGCAATAGTCCGCNTCCCAGTTTCGCTCACATGTTCAGAGGCATAC
TTGATCCAGTGCCCTTTACTGGGCTGCTGAACTTATTTAGNCCAGTGGTCTATCTTGG
CAGCATAGATACCTGACAAGTAGTCCGAGGGATCATACTGTTAAATGCCACTTTACC
ATTTAATCGGCGTCAATTCGGCTCTAGACTCCCATGTTCGGGGGTATTGTANGAACT
TACACTATTATGCTGTTTAAGATGGGATTTTTCAGTTCTTTAGCCAGTCCCATCAAGA
ATTTAAGGAATTCCGGTGGGTTACAAATTGAATACCTCGGGAAATTCNATATAGATA
ATGNTTTCCCCTTGCAAGTTCAAGGCTTGGGAAACCTGT 
> gb|CP000236.1|  Ehrlichia chaffeensis str. Arkansas, complete genome 
Length=1176248 
 
 
  Subject start position 
 Features in this part of subject sequence: 
   hypothetical protein 
 
 Score =  154 bits (170),  Expect = 3e-38 
 Identities = 220/278 (79%), Gaps = 40/278 (14%) 
 Strand=Plus/Plus 
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Query  24      TAGTGCATATCAAGTGTAAGCATGTAGTGGTATTATCTATATAATAAGTAATAGTATATT  83 
               |||||||||| |||||||||||||||||||  ||   ||| ||||||| |||||   ||| 
Sbjct  374192  TAGTGCATAT-AAGTGTAAGCATGTAGTGGATTT---TAT-TAATAAG-AATAG---ATT  374242 
 
Query  84      ACTATCCTAATAGTAATATGGGGAGTATTAGATAAGCTTTGTTTTGATCTATGTATTTAG  143 
                || |||||  |   |||||||||| ||| |||||||||||||||||||||   |||||| 
Sbjct  374243  TCT-TCCTATGA---ATATGGGGAG-ATTTGATAAGCTTTGTTTTGATCTA--GATTTAG  374295 
 
Query  144     ATCCTCAGGATTTTGTAACACAAGTTATACGATTCTAGTGCATGTTTTTAGCATCTTTAT  203 
               ||||||| |||||||  | |||||||||| |||| || |||| |||||  || || |||| 
Sbjct  374296  ATCCTCA-GATTTTG--AAACAAGTTATA-GATT-TA-TGCA-GTTTT--GC-TC-TTAT  374344 
 
Query  204     ATTCGAATATACTTGGATCTTAGGTTTAGTACAATTTCTTGATTAGAAATGATGATATCT  263 
               ||| ||| ||  |||||||||| | ||||||||||||||||  | ||||||| ||| ||| 
Sbjct  374345  ATTTGAA-AT-TTTGGATCTTAAG-TTAGTACAATTTCTTG--TTGAAATGA-GAT-TCT  374397 
 
Query  264     TGTGCCACATTCAGACAACACTAAT-TGCTAAGTATAA  300 
                 | ||||||    | ||||||||| |  | ||||||| 
Sbjct  374398  --TTCCACAT---CAAAACACTAATGTAATTAGTATAA  374430 
 
Sequence matched with transposon sequence- ITR-AmTr-Cherry-Spec-ITR: 
 
Query  373   TGGCTTGATACAGTACCCCGGATCTAATGCTTAGCGATGCCTGCAGAGTCGACTCTAGCA  432 
             ||||| |||| ||| |||||| ||||| |||| || |||||||||| ||||||||||| | 
Sbjct  1829  TGGCT-GATA-AGT-CCCCGG-TCTAA-GCTT-GC-ATGCCTGCAG-GTCGACTCTAG-A  1779 
 
Query  433   TGTATGTATGCTCGACTACCT  453 
             |   | | ||| ||||||||| 
Sbjct  1778  T---TATTTGC-CGACTACCT  1762 
 
 
Analysis was done similarly in mapping the other insertions described in figure 3.14. 
  
Genomic insertion region verification by PCR and sequencing analysis 
 
For verification of the insertion sites mapped through ST-PCR and sequencing, 
we designed primer sets for the amplification of a segment from all 8 genomic insertion 
sites. In each primer set, one primer was designed to bind the 5’ or 3’ end of the 
inserted transposon sequence and the second primer was designed to bind to the 
genomic region upstream or downstream of the insertion sites. Genomic DNA isolated 
from the mutants was used in amplification (Figure 3.15).  The resulting PCR products 
were subjected to automated DNA sequence analysis. These analyses verified the 
results of ST-PCR.  Specifically, all 8 insertion site-specific amplifications resulted in the 
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generation of the predicted amplicons which also contained the DNA sequence as 
identified by the ST-PCT and sequence analysis.  
Modifying the transposon plasmids for improving the efficiency of creating 
transposon mutations in E. chaffeensis 
 
The plasmids pHIMAR1-UV-SS (transposon plasmid with Amtr promoter GFPuv 
and spectinomycin resistance gene) and pET28AMTR-A7-HIMAR (transposase 
expression plasmid) represent a two-plasmid set used for creating transposon 
mutagenesis in the rickettsial pathogen, A. phagocytophilum [81].  This plasmid pair is 
similar to the single plasmid containing both the transposon insertion sequences and 
transposase gene sequences which were used in creating mutations in E. chaffeensis. 
Both the systems, however, use the Amtr promoter and spectinomycin resistance gene, 
aad.  Although we succeeded in creating mutations with the single plasmid system 
containing the Amtr and aad gene, we reasoned that the use of a constitutively 
expressed E. chaffeensis promoter may be more efficient in creating mutations with 
higher efficiency. Secondly, as spontaneous mutations are possible which confer 
resistance against spectinomycin, we reasoned that it is desirable to use an alternate 
antibiotic resistance cassette such as the chloramphenicol acetyl transferase resistance 
gene (CAT gene) in place of aad gene. Therefore, I focused to optimize the two plasmid 
system by replacing the Amtr promoter with the E. chaffeensis transcription elongation 
factor gene promoter (Ech-tuf promoter) and aad gene with CAT gene in the pHIMAR1-
UV-SS plasmid.  The Ech-tuf promoter was selected because it is constitutively 
expressed in E. chaffeensis during its growth in both vertebrate and tick cell 
environment (unpublished results of Cheng et al.).  Moreover, we reasoned that it 
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serves as an efficient promoter because this is involved in transcribing several genes 
involved in the protein biosynthesis. Similarly, we opted CAT gene in place of aad gene, 
because spontaneous mutations are less likely arise against chloramphenicol. Standard 
molecular manipulations of restriction enzyme digestions, cloning and sequence 
evaluations were performed on the pHIMAR1-UV-SS plasmid to replace the Amtr 
promoter and the aad gene (Figures 3.16-3.21).  The modified plasmid was named as 
pHimar UV-SS cat 224 .This plasmid is now ready for use in transposon experiments to 
be performed on E. chaffeensis.   
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Figure 3.1 pCis mCherry –SS A7 –Himar plasmid map (prepared by Munderloh’s group)  
pCis cherry –SS A7 –himar plasmid containing the Himar 1 transposase gene and a 
transposon segment having the gene sequences encoding for mCherry and the 
spectinomycin resistance gene (aad gene). The transposon segment is flanked by the 
left and right himar inverted repeats to facilitate recognition of the transposase enzyme. 
To facilitate transposase, mCherry and add gene expression, the A. marginale AmTR 
promoter is inserted in front of these genes.  
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Figure 3.2: pCis GFPUV –SS A7 –Himar plasmid 
This plasmid is essentially the same of pCis cherry –SS A7 –himar, except that the 
mCherry gene coding sequence is replaced with GFP-UV coding sequence. 
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Figure 3.3 : Southern blot experiment  
Genomic DNAs were isolated from E. chaffeensis transposon mutants prepared using 
the pCis GFPuv–SS A7 or pCis mCherry–SS A7–himar plasmids and digested with BgII 
(lanes 1 and 3) or Hind III (lanes 2 and 4).  The DNAs were resolved on a 0.9 % 
agarose gel, transferred on to a nylon membrane and probed with a 32P labeled 
spectinomycin resistance gene specific probe. Lanes 1 and 2, genomic DNA isolated 
from mCherry mutants; lanes 3 and 4, genomic DNA from GFPuv mutants; lanes 5, 
wild-type DNA, lane 6 blank lane, and lane 7, PCR product used for probe synthesis to 
serve as the positive control.  
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Figure 3.4: Southern blot experiment 
 
Genomic DNA from Himar1 transposon E. chaffeensis mutants was assessed by DNA 
blot analysis using a spectinomycin resistance gene (aad) probe following digestions 
with different restriction enzymes (N, NdeI; S, Spe I; Bs, Bsrg I; E, EcoR V; B, Bgl II and 
Hind III). E. chaffeensis genomic DNA was recovered from the mutant organisms of 
mCherry plasmid transformed (m) or GFPuv plasmid transformed organisms (g) grown 
in ISE6 tick cells (I) or DH82 macrophages (D). It was digested with different restriction 
enzymes, resolved on a 0.9 % agarose gel and transferred on to a nylon membrane. 
Then they were hybridized using a 32P labeled aad gene specific probe. 
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Figure 3.5: Southern blot experiment 
Genomic DNAs from the mCherry and GFPuv (1st experiment) mutants propagated in 
DH82 cultures was also assessed at two different randomly selected harvest times 
(separated about 1 month apart) to evaluate the stability of the transformants over time. 
The lanes mD1 and mD2 represent two different days when mCherry mutants were 
harvested, and gD1 and gD2 represent different harvest dates for GFPuv mutants. 
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Figure 3.6: Cartoon Illustrating the ST-PCR 
The sets of primers P1/P1*/P1** and P3/P3*/P3** are primers specific to inserted 
transposon sequence and P2 and P4 are the random primers. The random primer P2 
contains three segments; the 5’ end defined sequence, the middle segment containing 
ten random nucleotides and the 3’ end contained GATAT.  P4 has just the 5’ end 
defined sequence.  
 
P 2 (RRG 1260) - 5’ GGCCACGCGTCGACTAGTACN (10) GATAT 3’ 
P4 (RRG 1261) - 5’ GGCCACGCGTCGACTAGTAC 3’ 
P1/P1*/P1** - RRG 1259, RRG 1194, RRG1264 
P3/P3*/P3** - RRG 1258, RRG 1194, RRG 1202  
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  Figure 3.7 First round ST-PCR 
First round ST-PCR with random primer RRG 1260 (P2) paired with RRG 1259 (lanes 2 
and 6), or RRG 1264 (lanes 3, 4, 7 and 8) (P1, P1* respectively). Lanes 1 and 5 are 
negative controls; lanes 2, 3 and 4 are the ST-PCR products using GFPuv transposon 
mutants genomic DNA as the template; Lanes 6, 7 and 8 are the ST-PCR products from 
the mCherry transposon mutants genomic DNA. Lanes M at the left and right ends 
contained 1 KB + DNA ladder and lambda DNA digested with Hind III restriction 
enzyme, respectively. PCR products were resolved on a 0.9% agarose gel.  
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Figure 3.8: Second round ST-PCR   
Second round ST-PCR performed with P4 (RRG 1261) and with (P3, P3*, P3**) RRG 
1258 (Lane 3 and 5), or RRG1194 (lanes 4 and 6), or RRG1202 (lanes 1 and 2) . Lanes 
1, 2and 3 are GFP; lanes 4, 5 and 6 are mCherry derived DNA. B, blank lane, Lane M is 
1kb + DNA ladder. PCR products were resolved on a 0.9 % agarose gel at 90 volts/ 
2hours. 
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Figure 3.9: Gel isolated ST-PCR products 
The ST-PCR DNA bands from the gel (figure 3.7) were isolated and purified. All the 
samples were resolved on 0.9 % agarose gel; Lanes 1 through 14 represent the purified 
DNA from different bands isolates from the resolved gel. Lanes M at the left and right 
ends contained 1 KB + DNA ladder and lambda DNA digested with Hind III restriction 
enzyme, respectively. 
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 Figure 3. 10: 2
nd
 ST-PCR experiment- first round PCR 
First round ST-PCR with Random primer RRG 1260 (P2) paired with RRG 1194 (lane 3 
and 7) or, RRG 1259 (lanes 1, 2, 5 and 6), or RRG 1264 (lanes 4 and 8) (P*/P*1/P**1). 
Lanes 1, 2, 3 and, 4 are GFP; lanes 5, 6, 7 and, 8 are mCherry. Lane M is L- 1kb+ 
ladder. PCR products were resolved on a 0.9 % agarose gel. 
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Figure 3.11: Second ST-PCR experiment- second round PCR  
Second round ST PCR with P4 (RRG 1261) and P3/P*3/P**3; RRG 1258 (lanes 1, 2, 5, 
and 6) or RRG1194 (lanes 3 and 7) or RRG1202 (lanes 4, 8 and 9). Lanes 1, 2, 3, and 
4 are GFP; lanes 5, 6, 7, 8 and 9 are mCherry. B, blank lane, lane M is 1kb + DNA 
ladder. Products resolved on a 0.9% gel at 100 volts /1.5 hours. 
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 Figure 3.12: 3
rd
 ST-PCR experiment –first round PCR 
Third ST-PCR first round products resolved on 0.9 % agarose gel; 1st round ST-PCR 
with random primer RRG 1260 (P2) paired with RRG 1194. Lanes 1 and 2 are GFP; 
lanes 3 and 4 are mCherry.  Lanes M at the left and right ends contained 1 KB + DNA 
ladder and lambda DNA digested with Hind III restriction enzyme, respectively. 
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Figure 3. 13: 3
rd
 ST-PCR experiment – second round PCR  
Third ST-PCR with random primers RRG 1260 paired with RRG 1258. Second round 
products resolved on 0.9% agarose gel; 2 dilutions of the1st round products were used 
as templates for 2nd round. Lanes 1, 2, 3 – GFP (dilution 1- 1:5 dilution); lanes 4, 5, 6 - 
mCherry (dilution 1). Lanes 7, 8, 9 - GFP (dilution 2); lanes 10, 11, 13 – mCherry 
(dilution 2 is 1:10 dilution). Lanes M at the left and right ends contained 1 KB + DNA 
ladder and lambda DNA digested with Hind III restriction enzyme, respectively 
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Figure 3.14:  Mapped transposon insertion sites  
A cartoon illustration of the E. chaffeensis genomic locations mapped for the transposon 
mutants. E. chaffeensis genomic DNA from three independent transformations with 
mCherry and GFPuv Himar1 transposon plasmids was used to determine the 
integration locations by inverse PCRs and ST-PCRs followed by DNA sequence 
analysis. Genomic locations of the insertion sites and the genes at or near the 
insertions, as per the whole genome data (GenBank # CP000236.1), were presented. 
The insertions in mCherry transformants are shown as solid red bars, and insertions in 
GFPuv transformants are depicted as solid green bars 
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Figure 3.15: Validation of transposon insertions in the E. chaffeensis genome. 
The insertion sites in the E. chaffeensis genome were verified by PCR with primers 
designed to bind to the genomic region upstream of the insertion sites (forward primer) 
and to the inserted DNA (spectinomycin resistance gene) (reverse primer). Product 
sizes for all 8 insertions are different and the predicted size amplicons were observed 
only in PCRs containing the mutant genomic DNAs as the templates. Lanes 1- 8 
different mutants.  N, no template control; D, wild type E. chaffeensis DNA used as the 
template; M, 1 kb+ DNA molecular weight marker.
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Figure 3.16: Restriction digestion of Himar1-UV-SS plasmid (single digestion) 
The transposon plasmid pHIMAR1-UV-SS isolated from overnight E.coli cultures was 
digested with restriction enzyme EcoRI to make it linear; The products were resolved on 
0.9% agarose gel AT 108 VOLTS / 2 hours ; the band size is 4.5 kb.  M- 1kb plus DNA 
molecular weight marker. 
Lanes 1, 2 and 3 – plasmid DNA isolated from three clones.  
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Figure 3.17: Restriction digestion of Himar1-UV-SS plasmid (double digestion) 
Plasmid pHIMAR1-UV-SS digested with two restriction enzymes with ECORI and 
XbaI.Products were resoled on 0.9% agarose gel at 120 volts/2hours.  The lower band 
is around 1755 bp and the upper band is 2804 bp. M (far left) is 1kb + ladder, M (far 
right) is Hind III digested lambda DNA marker.  
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Figure 3.18: Restriction digestion of ML.cat224 plasmid 
Transposon plasmid ML.cat 224 containing Echtuf promoter and chloramphenicol acetyl 
transferase resistance gene was digested with restriction enzyme SpeI to release the 
1.6 kb segment containing Echtuf promoter and chloramphenicol acetyl transferase 
resistance gene. The product was resolved on 0.9 % gel. Lanes 1 and 2 are plasmid 
isolated from 2 clones.  Lane M is 1kb plus DNA ladder. 
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Figure 3.19:  pHimar UV-SS cat 224 plasmid selection 
1.6kb gene segment containing Echtuf promoter and chloramphenicol acetyl transferase 
resistance gene form the Ml.cat 224 plasmid was ligated in to the Himar- uvss plasmid 
vector to create pHimar UV-SS cat 224.  
Lanes 1- 12 - Himar-uvss.Ml.cat 224 plasmids isolated from several clones; uncut and 
resolved on 0.9 % gel; Lanes M at the left and right ends contained 1 KB + DNA ladder 
and lambda DNA digested with Hind III restriction enzyme, respectively. 
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Figure 3.20: pHimar UV-SS cat 224 plasmid verification by single restriction enzyme digestion 
The new transposon plasmid Himar-uvss.Ml.cat 224 plasmid digested with single 
restriction enzyme Hind III to give 4.5 kb size fragment. Lanes 1, 2, 3 and 4 are four 
different samples; M (far left) is 1 Kb + DNA ladder, M (far right) is Hind III digested 
Lambda DNA.  Products were resolved on 0.9% gel at 120 volts/ 1.5 hours. 
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Figure 3.21: pHimar UV-SS cat 224 plasmid verification by single and double restriction enzyme 
digestion 
The transposon plasmid Himar-uvss.Ml.cat 224 plasmid digested with single and double 
restriction enzymes. Lane 1 is XhoI digestion, lane 2 is SalI digestion, lane 3 is NcoI 
digestion and lane 4 is Spe I and Hind III double digestion. M (far left) is 1 Kb + DNA 
ladder M (far right) is Hind III digested Lambda DNA. Products were resolved on 0.9% 
gel at 120 volts/ 1.5 hours 
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E. chaffeensis  is an emerging pathogen causing disease in both people (HME) 
and various vertebrate animals which include dog, coyote, goat and deer [1, 8]. HME 
was first discovered in 1987 and subsequently reported in many parts of the USA and 
several other countries from western hemisphere, Europe, and Asia [89-93].  Despite 
the significant health concern, much remains to be understood about how E. 
chaffeensis causes pathogenesis and how it successfully survives in tick and vertebrate 
hosts. Recent studies suggest that the pathogen alters its protein expression in dual 
host environments and the protein expression differences are also shown to be 
influencing the host response and the pathogen persistence [94].  An important goal of 
the research for our group is to understand the molecular basis of the E. chaffeensis 
pathogenesis and also to understand the host-specific differences in gene expression of 
the pathogen. One of the means to investigate the importance of host-specific gene 
expression differences is by employing mutational analysis methods. In support if this, 
we conducted experiments to create transposon mutations in E. chaffeensis. 
Specifically, Himar transposon mutagenesis was performed which resulted in creating 
mutations in multiple genomic locations. In this study, I utilized a rapid and efficient in 
vitro amplification method to locate the genomic sites where the transposon insertions 
were introduced. The ST-PCR method used in this study aided in identifying and 
validating 8 genomic sites in E. chaffeensis genome. Experiments described in my 
research are also important in further verifying the insertion mutation locations by 
conducting insertion-specific PCRs and sequencing analysis. Together, the data 
described aided in the identification of mutations within the coding regions of two genes, 
Ech_0379 and Ech_0601 and one at immediate downstream to the coding region of a 
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gene, Ech_0230. These three mutations caused the loss of gene activity (research 
results of our group). Five mutations were also identified at intergenic sites of E. 
chaffeensis chromosome and these mutations had no impact of the expression genes 
located at both upstream and downstream from the insertion sites. The RNA analysis 
was performed and published as part of the study conducted by our research team [88].   
Animal infection studies also conducted by our research team further demonstrated that 
two of the three gene inactivation mutations at Ech_0230 and Ech_0379 caused 
attenuated growth of the mutant organisms in vivo when assessed in white-tailed deer. 
Together, these data demonstrate the value of the mutagenesis in identifying genes 
critical for the pathogen’s growth in vivo. Importantly, defining the location of mutations 
within the genome of the organism is a critical step in initiating the detailed 
investigations of understanding the importance of specific gene expression to the 
pathogen. Moreover, the methods established in this study will lead the way for 
additional studies to create mutations at numerous genomic locations in E. chaffeensis 
and to determine which genes are critical for the pathogen’s in vivo growth and in 
causing pathogenesis. These studies are now actively pursued by our research team 
 As part of the MS research, I also modified the existing transposon 
plasmids (prepared earlier for use in Anaplasma species mutational analysis) for use in 
improving the efficiency of transposon mutagenesis in E. chaffeensis. In particular, a 
transposon insertion plasmid was by replacing the Anaplasma species promoter with a 
constitutively expressed E. chaffeensis gene promoter, Ech-tuf.  Likewise, the antibiotic 
resistance cassette conferring resistance to spectinomycin was replaced with 
chloramphenicol resistance gene, CAT. This modified construct, although not tested as 
73 
 
part of my current research project, is likely valuable for future experiments in improving 
the transposon efficiency in E. chaffeensis. This is an important goal for our research 
because our first set of transposon mutagenesis experiments resulted in a very limited 
number of mutants. (Eight mutants were reported in the current study.)  Although this is 
an impressive achievement for the Ehrlichia field as this is the first mutational analysis 
study, high efficiency mutagenesis is needed to map the functions of large numbers of 
genes present in the genome of E. chaffeensis.  Therefore, the modifications to Himar 
mutagenesis plasmids are important in optimizing the mutational experiments for the 
generation of mutant library containing large numbers of mutants.  
In summary, the research conducted as part of my MS graduate education led to 
the standardization and the utilization of genome mapping methods needed for locating 
transposon insertion sites efficiently. This research also is a stepping point for improving 
the efficiency of transposon mutagenesis in E. chaffeensis. 
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